Ignite Creation Date:
2024-05-05 @ 5:35 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480194
Status:
COMPLETED
Last Update Posted:
2012-05-07
First Post:
2007-05-24
Brief Title:
Evaluation of Safety of ZyComb In Patients With Common Cold - ZIP 3000 XY-005-IM
Sponsor:
Nycomed
Organization:
Nycomed
Study Overview
Official Title:
A Non-interventional Non-controlled Post-marketing Study to Obtain Knowledge of the Safety of ZyComb Xylometazoline Hydrochloride 05 mgmL and Ipratropium Bromide 06 mgmL for Symptoms of Common Cold in a Real-life OTC Setting
Status:
COMPLETED
Status Verified Date:
2008-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The objectives of the study are to obtain knowledge about the safety in use the patients general impression of the treatment and the pattern of use of ZyComb in an over-the-counter OTC setting
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None